Study reveals weight loss medications may improve outcomes for chronic sinus disease patients

by American Academy of Otolaryngology edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists (GLP-1RAs)—a class of medications primarily used for weight loss and diabetes management—may significantly improve post-surgical outcomes for patients with chronic rhinosinusitis with […]

Study reveals weight loss medications may improve outcomes for chronic sinus disease patients Read More »